gamma variant

Cocrystal Pharma (COCP.Q) announced today that its SARS-CoV-2 3CL protease lead CDI-45205 and several analogs showed potent in vitro activity against the SARS-CoV-2 Delta and Gamma variants. “These in vitro SARS-CoV-2…